DV
Dividend Vision

COLL — Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. (COLL)

Total return is 129.7% over the past 11.3 years, 218.3 points behind SPY at 348.0%. Its deepest 1-year drawdown was 48.4%.

Collegium Pharmaceutical is a single-stock equity holding in the healthcare sector with no ETF wrapper or fund structure—it functions as a direct stock investment rather than a diversified fund. The company does not currently pay dividends, resulting in no distribution rate or frequency, and lacks the expense ratio typical of ETFs since it is a publicly traded equity security. This holding appeals primarily to growth-oriented investors seeking exposure to pharmaceutical companies rather than income-focused investors seeking dividend payments.

COLL key facts

Asset type
Stock
Asset class
Equity
Inception date
05/07/2015
Distribution frequency
None
Last close
$28.23
Market cap
$915,605,568
Average volume
695329.0
Beta
0.763
Payout ratio
0.0
P/E ratio
22.0547
Forward P/E
3.7879
EPS
$1.28